Aortic Stent Grafts Market by Application and Geography - Forecast and Analysis 2022-2026

The aortic stent grafts market share is expected to increase by USD 781.72 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.22%.

The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (AAA and TAA) and geography (North America, Europe, Asia, and Rest of World (ROW)).

The market report also offers information on several market vendors, including Artivion Inc., B. Braun SE, Becton Dickinson and Co., Bentley InnoMed GmbH, BioStable Science and Engineering Inc., Braile Biomedica, Cardinal Health Inc, Cook Group Inc., Edwards Lifesciences Corp., Endologix LLC, Endospan Ltd, Getinge AB, InSitu Technologies Inc., LeMaitre Vascular Inc., Lifetech Scientific Corp, Lombard Medical Ltd., Medtronic Plc, Merit Medical Systems Inc., MicroPort Scientific Corp, S and G Biotech Inc, Terumo Corp, and W. L. Gore and Associates Inc. among others.

B. Braun SE - The company is privately held and headquartered in Germany. It is a global company generating USD 9,290 million in revenues and has around 66,234 employees. Its revenue from the global aortic stent grafts market contributes to its overall revenues and other offerings, but it is not a key revenue stream for the company. The company offers Aortic Stent Grafts namely Uni Graft W Aortic Arch, a single velour vascular prosthesis made of polyester, which has been impregnated with absorbable modified bovine gelatine. 

What will the Aortic Stent Grafts Market Size be During the Forecast Period?

Get the Aortic Stent Grafts Market Size Forecast by Download Report Sample

Parent Market Analysis

Technavio categorizes the global aortic stent grafts market as a part of the global healthcare equipment market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period. 

Aortic Stent Grafts Market: Key Drivers, Trends, and Challenges

The rising incidence of aortic aneurysms is notably driving the market growth, although factors such as the shortage of skilled endovascular surgeons may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. 

Key Aortic Stent Grafts Market Driver

The rising incidence of aortic aneurysms is a major factor driving the global market share growth. Aortic aneurysms are the most dangerous form of aneurysms, as they can lead to death if not treated on time. The incidence of aortic aneurysms is 5 to 10 out of every 100,000 people in the US. Aneurysms can be classified into thoracic aneurysms and abdominal aneurysms. Every year, approximately 500,000 people across the world are diagnosed with AAAs. The estimated incidence of TAAs is at least 5 to 10 out of every 100,000 people. Untreated AAAs can cause ruptures and lead to death. Hence, the need for the early diagnosis and treatment of AAAs is high. The prevalence of AAA is high among people above the age of 60 years, and the proportion of the geriatric population is increasing across the world. According to The World Bank Group and the National Institutes of Health (NIH), the proportion of the geriatric population of the global population is estimated to grow from 10% in 2021 to approximately 17% by 2050. The rising proportion of the geriatric population in the global population will increase the prevalence of aneurysms, which will drive the growth of the global market during the forecast period.

Key Aortic Stent Grafts Market Trend

Technological innovations is another factor supporting the global aortic stents market share growth. Stent grafts are used as an alternative to open surgeries. Diseases that are associated with the thoracic aorta are common among high-risk individuals. Hence, the risk of mortality and morbidity is high. FEVAR is guided to the aneurysm through the blood vessel by making a percutaneous incision in the groin. It can efficiently cover the branched arteries, as it has holes or fenestrations. These fenestrations are placed above the branched opening of vessels in order to ensure the uninterrupted flow of blood to the vital vessels during the placement of stent grafts. Fenestrated grafts offer a variety of benefits, such as lesser complications than open surgeries, short hospital stays, and quick recovery. The focus of research and development is shifting toward the filling of the aneurysm sac with a polymer in addition to stenting to address the issues with available stent graft technologies, such as migration and endoleaks. This is expected to eliminate the complications associated with traditional stent-grafts, which will reduce the chances of leaks and the migration of grafts. Technological advances and the introduction of technologically advanced products can reduce the need for traditional surgical procedures and eliminate several risks. Thus, such technological advancements will boost the growth of the global market during the forecast period.

Key Aortic Stent Grafts Market Challenge

The shortage of skilled endovascular surgeons will be a major challenge for the global market share growth during the forecast period. EVAR procedures are a key part of the treatment of AAA. The safety and efficiency of EVAR procedures that use aortic stent grafts for the treatment of AAA depend on the expertise and experience of surgeons. Surgeons should have a complete understanding of anatomic complexities, disease progression, and sophisticated imaging technologies to perform EVAR procedures using stent graft systems. They also require expertise to use complex grafts to avoid complications. EVAR procedures also require multi-disciplinary teams that comprise vascular surgeons, interventional radiologists, and anesthesiologists. The number of endovascular procedures, including EVAR procedures, is increasing significantly, owing to the growing proportion of the geriatric population, which is at a high risk of AAA and TAA. However, the number of endovascular surgeons is expected to remain stable. A large proportion of endovascular surgeons in North America are expected to retire in the next decade, which will cause a shortage. The rising number of endovascular surgeries in countries such as the UK is also expected to cause a shortage in the number of endovascular surgeons. The shortage of endovascular surgeons is pronounced in low and middle-income regions, such as Southeast Asia and Africa. Several countries in Asia have a limited number of dedicated endovascular surgeons. The shortage of skilled surgeons to perform EVAR procedures may hinder the growth of the global market during the forecast period.

This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Aortic Stent Grafts Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the aortic stent grafts market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report. 

Which are the Key Regions for Aortic Stent Grafts Market?

Get a glance at the market share of various regions Request PDF Sample now!

38% of the market’s growth will originate from North America during the forecast period. US is the key market for aortic stent grafts market in North America. Market growth in this region will be slower than the growth of the market in other regions.

The introduction and commercialization of advanced grafts for the treatment of aortic aneurysms will facilitate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The market in North America witnessed a slow growth in 2020, owing to the outbreak of COVID-19. Countries across North America were severely affected by the pandemic. In addition, disruptions in the supply chain for raw materials required for aortic stents manufacturing, the limited availability of the workforce, and a decline in the number of orders from hospitals for aortic stent grafts lowered the production volume to a certain extent during the first few months of 2020. 

What are the Revenue-generating Product Segments in the Aortic Stent Grafts Market?

To gain insights on the market contribution of various segments Request PDF Sample

The market share growth by the AAA segment will be significant during the forecast period. Stent grafts are widely used to treat AAA. The prevalence of AAA is higher than TAA. Hence, a greater number of stent grafts have been approved for the treatment of AAA. Thus, the AAA segment was the largest contributor of revenue to the global market in 2021.

This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on the post-COVID-19 impact on each segment. 

 

Aortic Stent Grafts Market Scope
Report Coverage	Details
Page number	140
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 5.22%
Market growth 2022-2026	USD 781.72 million
Market structure	Fragmented
YoY growth (%)	4.96
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key consumer countries	US, Germany, France, China, and Japan
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Artivion Inc., B. Braun SE, Becton Dickinson and Co., Bentley InnoMed GmbH, BioStable Science and Engineering Inc., Braile Biomedica, Cardinal Health Inc, Cook Group Inc., Edwards Lifesciences Corp., Endologix LLC, Endospan Ltd, Getinge AB, InSitu Technologies Inc., LeMaitre Vascular Inc., Lifetech Scientific Corp, Lombard Medical Ltd., Medtronic Plc, Merit Medical Systems Inc., MicroPort Scientific Corp, S and G Biotech Inc, Terumo Corp, and W. L. Gore and Associates Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Aortic Stent Grafts Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive market growth during the next five years
• Precise estimation of the market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behaviour
• The growth of the aortic stent grafts industry across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch